Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ: DMAA · Real-Time Price · USD
10.88
0.00 (0.00%)
Oct 27, 2026, 1:03 PM EDT - Market open
DMAA Market Cap
DMAA has a market cap or net worth of $264.13 million as of October 27, 2026. It is the 18,923rd most valuable company in the world and the 3,318th biggest in the United States. Its market cap has decreased by 23.60% in one year.
Market Cap
264.13M
Enterprise Value
264.46M
1-Year Change
-23.60%
Global Rank
Country Rank
#3,318 United States
Category
ChartMarket Cap Chart
Since the IPO on January 28, 2025, DMAA's market cap has decreased from $291.71M to $264.13M, a decrease of -9.45%. That is a compound annual growth rate of -5.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 264.13M | -24.04% |
| Dec 30, 2025 | 347.71M | 19.20% |
| Jan 28, 2025 | 291.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Muzero Acquisition | 273.75M |
| Southport Acquisition Corp. II | 271.97M |
| Dynamix Corporation III | 271.28M |
| Karman Line Acquisition | 267.98M |
| Catalyst Acquisition | 266.65M |
| Oaktree Acquisition Corp. III Life Sciences | 263.28M |
| FACT II Acquisition | 261.70M |
| Newbury Street II Acquisition | 261.18M |